恩捷股份(002812.SZ)披露A股定增情况:JP Morgan、UBS AG及中欧基金等均在列
格隆汇 9 月 2日丨恩捷股份(002812.SZ)发布非公开发行A股股票发行情况报告书暨上市公告书,根据投资者申购报价情况,并严格按照认购邀请书中确定的发行价格、发行对象及获配股份数量的程序和规则,确定此次发行价格72元/股,发行股数6944.4444万股,募集资金总额约50亿元。
股票上市时间:2020年9月4日(上市首日),新增股份上市日公司股价不除权,股票交易设涨跌幅限制。
此次发行对象最终确定为22家,此次发行配售结果如下:



Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.